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Abstract
Two new Standard Reference Materials (SRMs), SRM 3672 Organic Contaminants in Smokers’ 
Urine (Frozen) and SRM 3673 Organic Contaminants in Non-Smokers’ Urine (Frozen), have been 
developed in support of studies for assessment of human exposure to select organic environmental 
contaminants. Collaborations among three organizations resulted in certified values for 11 
hydroxylated polycyclic aromatic hydrocarbons (OH-PAHs) and reference values for 11 phthalate 
metabolites, 8 environmental phenols and parabens, and 24 volatile organic compound (VOC) 
metabolites. Reference values are also available for creatinine and the free forms of caffeine, 
theobromine, ibuprofen, nicotine, cotinine, and 3-hydroxycotinine. These are the first urine 
Certified Reference Materials characterized for metabolites of organic environmental 
contaminants. Noteworthy, the mass fractions of the environmental organic contaminants in the 
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two SRMs are within the ranges reported in population survey studies such as the National Health 
and Nutrition Examination Survey (NHANES) and the Canadian Health Measures Survey 
(CHMS). These SRMs will be useful as quality control samples for ensuring compatibility of 
results among population survey studies and will fill a void to assess the accuracy of analytical 
methods used in studies monitoring human exposure to these organic environmental contaminants.
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Introduction
Urine sampling is widely used to assess exposure to environmental pollutants because it is 
non-invasive, easily repeatable, and poses minimal or no collection risk to the donor [1]. In 
addition, urine is the bodily fluid used for the biomonitoring of compounds with short 
biological half-lives. Many environmental pollutants, including certain nicotine metabolites, 
polycyclic aromatic hydrocarbon (PAH), phthalate, phenol, paraben, and volatile organic 
compound (VOC) metabolites, are monitored in urine as part of studies such as the National 
Health and Nutrition Examination Survey (NHANES) [2] and the Canadian Health 
Measures Survey (CHMS) [3]. Quantitation of urinary metabolites has been used to assess 
exposure to the parent compounds [4, 5].
As part of ongoing collaborations with the Centers for Disease Control and Prevention 
(CDC) [6], the National Institute of Standards and Technology (NIST) has developed two 
new Standard Reference Materials (SRMs) for organic contaminants in urine, SRM 3672 
Organic Contaminants in Smokers’ Urine (Frozen) and SRM 3673 Organic Contaminants in 
Non-Smokers’ Urine (Frozen). These two materials have been characterized for 
hydroxylated PAHs (OH-PAHs), phthalate metabolites, phenols, parabens, VOC metabolites, 
creatinine, and the free forms of caffeine, theobromine, ibuprofen, nicotine, cotinine, and 3-
hydroxycotinine. In addition to CDC and NIST, the Institut National de Santé Publique du 
Québec (INSPQ) provided data for OH-PAHs.
As noted in the titles of the two SRMs, the sources of the two materials are from smokers 
(SRM 3672) and non-smokers (SRM 3673). Nicotine is the primary addictive compound in 
tobacco smoke, and exposure to tobacco products is often assessed by measuring cotinine, 
one of the major metabolites of nicotine. Cotinine can be easily detected in urine, plasma, 
and saliva [7]. In addition to nicotine, tobacco smoke contains over 8000 chemicals [8], such 
as PAHs and VOCs.
People are exposed to mixtures of PAHs through the incomplete combustion of organic 
compounds from sources such as vehicle emissions, charbroiled foods, and tobacco smoke. 
Upon exposure, PAHs are metabolized to hydroxylated metabolites (OH-PAHs) [2]. The 
OH-PAHs are conjugated to glucuronic acid or sulfate for elimination through urine [9]. The 
urinary concentrations of OH-PAHs have been used to assess the possible sources of human 
exposure to PAHs [10].
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Phthalates are used as plasticizers to make plastics more flexible for use in packaging film 
and sheets, garden hoses, inflatable toys, blood-storage containers, and medical tubing; 
phthalates may also be present in personal care products. Once phthalates enter a person’s 
body, they are converted into hydrolytic monoesters which may undergo further phase I and 
phase II transformations before urinary excretion [2]. Studies quantifying urinary 
metabolites have been used to identify possible routes of exposure [11].
Humans are exposed to phenols through industrial pollution, pesticide use, food 
consumption, and use of personal care products [2]. For example, bisphenol A (BPA) is used 
in the manufacture of polycarbonate plastics and epoxy resins; benzophenone-3 is used as an 
ultraviolet filter in cosmetic products and plastics; triclosan is used as a bactericide in soap 
and other personal care products; and parabens are common antimicrobial preservatives used 
in cosmetics, pharmaceuticals, and food and beverage processing. Similar to PAHs and 
phthalates, these environmental phenolic compounds are metabolized (e.g., conjugated) for 
urinary excretion [12].
Exposure to VOCs is ubiquitous, and chronic exposure to high levels of some VOCs may 
lead to cancer and neurocognitive dysfunction [2]. Most of the mercapturic acid metabolites 
of VOCs found in urine are specific to environmental exposure and have longer 
physiological half-lives compared to the parent compounds [13]. The concentrations of 
selected VOC metabolites in urine have been investigated as a potential tool for early 
detection of lung cancer [14].
SRMs 3672 and 3673 are the first frozen urine reference materials characterized for organic 
environmental contaminants. Exposure assessment relying on the urinary metabolites 
characterized in these materials can be used to identify exposure sources, follow exposure 
trends, and study potential health effects associated with exposures. Similar to the two serum 
and two human milk SRMs previously characterized for organic environmental 
contaminants [6, 15], these urine materials will be useful in validating methods used for 
exposure assessment and developing methods for future chemicals of concern.
Experimental
Sample preparation
In 2009 Solomon Park Research Laboratory (Kirkland, WA) acquired a 50 L pool of non-
smokers’ urine from donors who were not exposed to secondhand cigarette smoke and a 25 
L pool of smokers’ urine from donors who smoked more than a pack of cigarettes per day. 
The urine was filtered prior to aliquotting into amber glass bottles that are capable of 
withstanding ultra-cold temperatures. Each bottle was filled with 10 mL of urine and stored 
at −80 °C prior to shipping on dry ice to NIST.
OH-PAHs
The approach used for the value assignment of OH-PAHs consisted of combining results 
from analyses of the material at NIST, CDC, and INSPQ using three different methods all 
based on gas chromatography with mass spectrometry (GC/MS). At NIST, duplicate test 
portions of approximately 3 g from 10 vials of each SRM were gravimetrically transferred to 
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centrifuge tubes, spiked with a known amount of internal standard solution containing 1-
naphthol-d7 and 3-hydroxyphenanthrene-13C6, followed by the addition of sodium acetate 
and β-glucuronidase/aryl sulfatase. The samples were incubated at 37 °C for 18 h and then 
eluted through a Strata X (Phenomenex, Torrance, CA) solid-phase extraction (SPE) 
column. Following washing and elution, the samples were concentrated to 0.5 mL in toluene 
and transferred to an autosampler vial. N-methyl-N-(trimethylsilyl)trifluoroacetamide 
(MSTFA) was added, and samples were heated at 60 °C for 30 min and analyzed using 
GC/MS with a 0.25 mm i.d. × 60 m fused silica capillary column with a 5 % (mole fraction) 
phenyl methylpolysiloxane phase (0.25 μm film thickness; DB-5, Agilent Technologies, 
Wilmington, DE).
The CDC laboratory used GC coupled with isotope dilution high resolution MS (GC/ID-
HRMS) for the measurement of the OH-PAHs as described in Li et al. [9]. At INSPQ, the 
urine samples were spiked with internal standards (1-naphthol-13C6, 2-naphthol-13C6, 2-
hydroxyfluorene-d9, 3-hydroxyphenanthrene-13C6 and 1-hydroxypyrene-13C6). The urinary 
metabolites were hydrolyzed with β-glucuronidase followed by extraction with hexane at 
neutral pH. These extracts were then evaporated, derivatized with MSTFA, and analyzed 
using GC coupled with tandem mass spectrometry (GC/MS/MS) on a proprietary non-polar 
column (DB-XLB, 30 m × 0.25 mm × 0.10 μm film thickness). Multiple reaction monitoring 
(MRM) mode was used to quantify the OH-PAHs following an electronic impact (EI mode) 
[16]. A total of 20, 24 and 4 aliquots were analyzed by NIST, CDC, and INSPQ, 
respectively.
Metabolites of phthalates, phenols and parabens, and volatile organic compounds
The on-line SPE high performance liquid chromatography/isotope dilution tandem mass 
spectrometry (LC/MS/MS) methods used at CDC for the quantification of phthalate (18 
aliquots of each SRM) and phenol and paraben (6 aliquots of each SRM) metabolites are 
described in Silva et al. [17], Ye et al. [12], and Ye et al. [18]. BPA was quantified at NIST 
using a method adapted from Arakawa et al. [19]. Aliquots of approximately 1 g were taken 
from six vials of each SRM. An internal standard solution containing 13C12-BPA was added 
followed by the addition of β-glucuronidase. Samples were incubated at 37 °C for 120 min. 
An amino SPE column was used to remove some of the potential interferences. MSTFA 
containing 1 % (volume fraction) trimethylchlorosilane (TMCS) was added to the 
concentrated sample followed by incubation at 60 °C for 20 min prior to GC/MS analysis on 
a 0.25 mm i.d. × 30 m fused silica capillary column with a 5 % (mole fraction) phenyl 
methylpolysiloxane phase (0.25 μm film thickness; HP-5MS). The ultra-high performance 
liquid chromatography -electrospray ionization tandem mass spectrometry method used at 
CDC for the quantification of VOC metabolites is described in Alwis et al. [13]. Three 
aliquots of each SRM were quantified for VOC metabolites.
Additional analytes
Creatinine was quantified at NIST using liquid chromatography with mass spectrometry 
(LC/MS) [20]. Samples of the thawed urine were spiked with creatinine-d3 followed by the 
addition of water and a hydrochloric acid (HCl) solution to bring the final concentration to 
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0.01 mol/L HCl. LC/MS measurements utilized a Luna C18 column, 0.25 cm × 4.6 mm, 5 
μm particle (Phenomenex, Torrance, CA) with single-ion monitoring.
Free (i.e., non-conjugated) levels of ibuprofen, caffeine and theobromine, nicotine, cotinine 
and 3-hydroxycotinine were measured at NIST using liquid/liquid extraction with 
chloroform followed by GC/MS analysis similar to that described in Man et al. [7]. 
Isotopically-labeled nicotine, ibuprofen, caffeine, cotinine, hydroxycotinine, and 
theobromine were used as the internal standards in the NIST modification of the method. 
The GC/MS analysis used a 0.25 mm i.d. × 30 m fused silica capillary column with a 50 % 
(mole fraction) trifluoropropyl methylpolysiloxane phase (0.25 μm film thickness; DB-210).
Results and discussion
Currently certified, reference, or information values are provided in NIST SRMs that are 
characterized for chemical composition. The categorization of the assigned value is based on 
the number and independence of the analytical methods used, source of the results, and 
degree of confidence in the accuracy of the assigned value [21]. For natural-matrix SRMs, 
the assignment of certified mass fraction values is typically based on the combination of 
results from two or more independent methods [21].
For the two SRMs evaluated in the current study, SRM 3672 and SRM 3673, the certified 
mass fraction values for the OH-PAHs (Table 1) are based on combining data from three 
institutes: NIST, CDC, and INSPQ. The agreement among the three data sets was good, as 
shown in the Electronic Supplementary Material (ESM) Tables S1 and S2, with the relative 
uncertainties ranging from 1 to 24 % with the majority <15 %. Each method used a 
hydrolysis step followed by extraction and derivatization with the final analysis using GC 
with either low-resolution MS (NIST), high-resolution MS (CDC), or tandem MS (INSPQ). 
There are other published methods using LC with fluorescence detection [22] or MS/MS 
[23]; however, these LC-based methods have some analytical challenges, such as interfering 
peaks, particularly for the hydroxynaphthalenes, and coelution of several 
hydroxyphenanthrenes.
The values for the OH-PAHs in SRM 3672 and 3673 fall within the ranges reported in 
NHANES [2] and the CHMS [3]. The mass fraction of 4-hydroxyphenanthrene is the lowest 
in both materials (<0.05 μg/kg) and that of 1-hydroxynaphthalene is the highest. Except for 
1-hydroxynaphthalene, the mass fraction of each hydroxylated PAH is higher (3 times to 84 
times) in the smokers’ urine (SRM 3672) than in the non-smokers’ urine (SRM 3673). 
Interestingly, 1-hydroxynaphthalene is 6 times lower in SRM 3672 than in SRM 3673, while 
2-hydroxynaphthalene is 6.5 times higher in SRM 3672 than in SRM 3673, following an 
expected and similar pattern as the remaining PAH metabolites. This suggests that a source 
other than naphthalene contributed to the levels of 1-hydroxynaphthalene in the non-
smokers’ urine. It has been reported that 1-hydroxynaphthalene is also the main metabolite 
of carbaryl (1-naphthyl-N-methylcarbamate), a major active ingredient in commonly used 
broad spectrum pesticides accounting for more than 85 % of urinary carbaryl metabolites 
[24, 25]. However, the inconsistency in levels of 1-hydroxy naphthalene could also be 
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caused by the relatively small number of subjects donating urine to the two SRMs (fewer 
than 5 subjects per SRM).
In 2008, CDC published geometric means for urinary OH-PAHs in US adults over 20 years 
of age for both smokers and non-smokers [26]. Other than 1-hydroxynapthalene and 1-
hydroxypyrene, the certified values for the OH-PAHs in the smokers’ urine material, SRM 
3672, are just slightly higher (within 2 %) or lower than the geometric means for smokers in 
the US population. The certified value for 1-hydroxynapthalene is 500 % higher and for 1-
hydroxypyrene 66 % higher in SRM 3672 than the US smokers. Other than 1-
hydroxynaphthalene, the certified values for the OH-PAHs in the non-smokers’ urine 
material, SRM 3673, are lower than the geometric means for the non-smokers’ urine in the 
US population. The certified value for 1-hydroxynapthalene is 140 times higher in SRM 
3673 than the geometric mean for non-smokers in the US. This comparison is another 
indication of exposures to sources other than cigarette smoke contributing to the 
concentrations of some PAH metabolites, particularly 1-hydroxynapthalene. 
Chetiyanukornkul et al. [22] attributed some of the differences that they noted in their study 
to exposure to traffic exhaust and biomass burning. Because we do not have information on 
the donors in this study, it is impossible to draw any conclusions regarding the nature of the 
exposure sources. With SRMs 3672 and 3673 being the first reference materials 
characterized for OH-PAHs, they will be useful in future studies to verify the methods used. 
In a study recently published by CDC, Li et al. [27] used SRMs 3672 and 3673 to validate a 
new GC-MS/MS method for quantifying 21 metabolites of methylnapthalenes and PAHs in 
human urine. In the development of the method, they confirmed the certified values for the 
OH-PAHs [27].
The urine SRMs are the third in a series of biological fluids that were prepared as spiked and 
unspiked pairs. (The other two materials are human serum and milk [6].) As was done for 
the serum and milk, a spiked non-smokers’ urine was prepared; the spiking solution 
contained 25 OH-PAHs in acetonitrile. When the OH-PAHs were quantified in the spiked 
material, however, the mass fractions were not statistically different than those in the 
unspiked non-smokers’ urine. A separate stability study was then conducted to assess 
stability of unconjugated OH-PAHs spiked into urine. This was done by combining the 
contents from 10 vials of the non-smokers’ urine chosen at random and spiked with a 
solution of the OH-PAH standards gravimetrically prepared in acetonitrile. The spiked urine 
was then aliquoted into 2 mL vials and stored at −80 °C. Three aliquots of the spiked urine 
were removed from the freezer and the mass fractions of the OH-PAHs measured at day 0, 1, 
3, 7, and 14. As can be seen in Fig. 1 the OH-PAHs spiked to urine in their free 
unconjugated form are not stable and are decreasing in concentration up to day 7 after which 
the concentrations appear to have stabilized. Due to the inherent instability of free form OH-
PAHs spiked into urine during storage at −80 °C, the decision was made to not release an 
SRM spiked with the free un-conjugated OH-PAHs. The naturally occurring conjugates 
(sulfate and/or glucuronic acid conjugates) present in urine have been stable during storage.
INSPQ and CDC have also investigated the stability of the OH-PAHs in other pooled urine 
samples (free and conjugated forms). In the study at INSPQ, 19 OH-PAH compounds were 
relatively stable at −20 and −80 °C over the course of a year. However, at 4 °C and room 
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temperature the free and conjugated species are less stable (degrading in less than 1 to 27 
weeks depending on the compound). In the studies at CDC, degradation of the free OH-
PAHs was noted but not to the same extent as for this pooled urine sample (data not shown). 
These differences in stability may be due to other constituents in the pooled urine samples; 
however, this cannot be proven by the limited studies done.
Reference values are provided for phthalate metabolites (Table 2), phenol and paraben 
metabolites (Table 3), VOC metabolites (Table 4), and additional compounds, including 
creatinine and non-conjugated caffeine, theobromine, ibuprofen, nicotine, cotinine, and 3-
hydroxycotinine (Table 5). The reference values for the metabolites of phthalates, phenols 
(except BPA), parabens, and VOCs are based on measurements made at CDC, and the 
reference values for the additional compounds are based on measurements made at NIST. 
The reference value for BPA is based on data using LC/MS/MS (CDC) and GC/MS (NIST). 
The agreement between the two sets of data for BPA is good with an expanded uncertainty 
for the reference values of 5 % (SRM 3672) and 6 % (SRM 3673).
As for the OH-PAHs, the mass fractions of the phthalate, phenol, paraben, and VOC 
metabolites are generally higher in the smokers’ urine than in the non-smokers’ urine. There 
are some exceptions including mono-n-butyl phthalate, benzophenone-3, ethyl and propyl 
paraben, and 2-thioxothiazolidine-4-carboxylic acid. Smoking is not a known relevant 
source of exposure for the phthalates, phenols, and parabens measured so it is not surprising 
that the differences in the mass fractions between the two materials are smallest for the 
phthalate metabolites (a factor of 2 or less). The differences in the mass fractions for the 
VOC metabolites in the two materials are generally larger (up to approximately a factor of 
6). These differences likely represent a larger contribution to the VOC concentrations from 
smoking compared to a more diverse contribution, such as exposure to plastics or use of 
personal care products for the phthalate concentrations. Similar to the OH-PAHs, the mass 
fractions of these metabolites fall within the ranges reported in NHANES [2, 28, 29] and 
CHMS [3].
The mass fractions for the additional analytes in Table 5 are based on analyses performed at 
NIST using LC/MS for creatinine and GC/MS for the remaining analytes. The mass 
fractions for nicotine, ibuprofen, caffeine, cotinine, theobromine, and 3-hydroxycotinine are 
for the free (non-conjugated) species only. The free ibuprofen, caffeine, and theobromine 
mass fractions are higher in the non-smokers’ urine than in the smokers’ urine.
Conclusion
SRM 3672 Organic Contaminants in Smokers’ Urine (Frozen) and SRM 3673 Organic 
Contaminants in Nonsmokers’ Urine (Frozen) are the first urine reference materials 
characterized for organic contaminants of interest in biomonitoring studies including PAH 
metabolites, VOC, phthalate, phenol, paraben, caffeine, theobromine, ibuprofen, creatinine, 
and tobacco markers. These materials will be useful for method development and for 
ensuring comparability among survey studies done throughout the world to assess human 
exposure to multiple classes of compounds including PAHs, phthalates, phenols, and VOCs.
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Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Fig. 1. 
Mass fractions for selected OH-PAHs as a function of time spiked into non-smokers’ urine 
and stored at −80 °C as a function of time since spiking. Top figure shows only 1-naphthol, 
middle figure shows only 2-naphthol, and bottom figure shows other compounds spiked into 
the urine sample
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Table 1
Certified mass fraction values (μg/kg) for OH-PAHs in SRM 3672 organic contaminants in smokers’ urine and 
SRM 3673 organic contaminants in non-smokers’ urine
SRM 3672 SRM 3673
1-Hydroxynaphthalene(a,b,c) 33.8±4.3(d) 207±33(e)
2-Hydroxynaphthalene(a,b,c) 8.57±0.16(d) 1.32±0.03(d)
9-Hydroxyfluorene(a,b,c) 0.331±0.077(e) 0.108±0.026(d)
3-Hydroxyfluorene(a,b,c) 0.420±0.018(d) 0.0384±0.0039(d)
2-Hydroxyfluorene(a,b,c) 0.854±0.015(d) 0.105±0.007(e)
4-Hydroxyphenanthrene(a,b,c) 0.0480±0.0045(d) 0.0102±0.0010(e)
9-Hydroxyphenanthrene(a,c) 0.959±0.061(d) 0.0114±0.0009(d)
3-Hydroxyphenanthrene(a,b,c) 0.123±0.007(d) 0.0271±0.0014(d)
1-Hydroxyphenanthrene(a,b,c) 0.133±0.014(e) 0.0479±0.0074(d)
2-Hydroxyphenanthrene(a,b,c) 0.0825±0.0007(e) 0.0242±0.0042(d)
1-Hydroxypyrene(a,b,c) 0.170±0.010(e) 0.0299±0.0018(d)
(a)NIST GC/MS analysis
(b)CDC GC/HRMS analysis; data were converted from ng/mL to μg/kg using the density of the urine (1.019 g/mL)
(c)
INSPQ GC/MS/MS analysis; data were converted from ng/mL to μg/kg using the density of the urine (1.019 g/mL)
(d)
The certified value is a weighted mean of average mass fractions, with one average from each of two or three analytical methods [30, 31]. The 
expanded uncertainty is the half-width of a symmetric 95 % parametric bootstrap confidence interval [32], which is consistent with the ISO Guide 
[33, 34]. The effective coverage factor, k, is 2
(e)
The certified mass fraction value is a weighted mean of the mass fractions from three analytical methods [30]. The uncertainty listed with each 
value is an expanded uncertainty about the mean [30, 31], with coverage factor k=2, calculated by combining within-method variances with a 
between-method variance [35] following the ISO Guide [33, 34]
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Table 2
Reference mass fraction values (μg/kg) for selected phthalate metabolites in SRM 3672 organic contaminants 
in smokers’ urine and SRM 3673 organic contaminants in non-smokers’ urine
SRM 3672(a,b) SRM 3673 (a,b)
Mono-carboxynonyl phthalate isomers(c) 1.92±0.06 1.49±0.02
Mono-carboxyoctyl phthalate isomers(d) 21.3±1.1 10.5±0.5
Mono-(2-ethyl-5-carboxypentyl) phthalate 35.2±1.7 30.1±1.0
Mono-(2-ethyl-5-hydroxyhexyl) phthalate 24.8±0.4 22.3±0.3
Mono-(2-ethyl-5-oxohexyl) phthalate 14.9±0.4 12.2±0.2
Mono-(2-ethylhexyl) phthalate 4.13±0.15 4.34±0.16
Mono-(3-carboxypropyl) phthalate 2.99±0.20 1.91±0.21
Monobenzyl phthalate 8.37±0.18 5.69±0.17
Monoethyl phthalate 94.5±3.08 0.2±2.1
Mono-isobutyl phthalate 6.40±0.28 5.18±0.26
Mono-n-butyl phthalate 10.6±0.5 11.2±0.7
(a)CDC analysis; data were converted from ng/mL to μg/kg using the density of the urine (1.019 g/mL)
(b)
The reference mass fraction value is the mean of results obtained using one analytical technique. The expanded uncertainty, U, is calculated as U 
= kuc, where uc is one standard deviation of the analyte mean, and the coverage factor, k, is determined from the Student’s t-distribution 
corresponding to the associated degrees of freedom and a 95 % confidence level for each analyte. The effective coverage factor, k, is 2.20
(c)
Mono-(2,7-dimethyl-7-carboxyheptyl) phthalate was used as the calibrant for the quantification of the mono-carboxynonyl phthalate isomers
(d)
Mono-(2,6-dimethyl-6-carboxyhexyl) phthalate was used as the calibrant for the quantification of the mono-carboxyoctyl phthalate isomers
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Table 3
Reference mass fraction values (μg/kg) for selected phenol metabolites in SRM 3672 organic contaminants in 
smokers’ urine and SRM 3673 organic contaminants in non-smokers’ urine
SRM 3672 SRM 3673
Bisphenol A(a,b) 3.05±0.16(c) 1.96±0.11(c)
2,5-Dichlorophenol(b) 1.77±0.06(d) 0.687±0.046(d)
Benzophenone-3(b) 191±5(d) 274±7(d)
Methyl Paraben(b) 113±2(d) 79.5±2.1(d)
Ethyl Paraben(b) 8.12±0.20(d) 10.3±0.3(d)
Propyl Paraben(b) 17.6±0.3(d) 21.6±0. 6(d)
Butyl Paraben(b) 11.1±0.2(d) 1.11±0.03(d)
Triclosan(b) 17.7±0.5(d) 6.27±0.32(d)
(a)NIST analysis GC/MS
(b)CDC analysis; data were converted from ng/mL to μg/kg using the density of the urine (1.019 g/mL)
(c)
The reference value is a weighted mean of average mass fractions, with one average from each of two analytical methods [30, 31]. The expanded 
uncertainty is the half-width of a symmetric 95 % parametric bootstrap confidence interval [32], which is consistent with the ISO Guide [33, 34]. 
The effective coverage factor, k, is 2
(d)
The reference mass fraction value is the mean of results obtained using one analytical technique. The expanded uncertainty, U, is calculated as U 
= kuc, where uc is one standard deviation of the analyte mean, and the coverage factor, k, is determined from the Student’s t-distribution 
corresponding to the associated degrees of freedom and a 95 % confidence level for each analyte. The effective coverage factor, k, is 2.20
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Table 4
Reference mass fraction values (μg/kg) for selected VOC metabolites in SRM 3672 organic contaminants in 
smokers’ urine and SRM 3673 organic contaminants in non-smokers’ urine
Parent compound Metabolite Common name SRM 3672(a,b) SRM 3673(a,b)
Acrolein N -Acetyl-S-(3-hydroxypropyl)-L-cysteine 3HPMA 1080±40 184±13
N -Acetyl-S-(2-carboxyethyl)-L-cysteine CEMA 200±10 53.9±7.4
Acrylamide N -Acetyl-S-(2-carbamoylethyl)-L-cysteine AAMA 122±1 53.9±7.4
N -Acetyl-S-(2-carbamoyl-2-hydroxyethyl)-L-cysteine GAMA 30±5.2 53.9±7.4
Acrylonitrile N -Acetyl-S-(2-cyanoethyl)-L-cysteine CYMA 126±8 53.9±7.4
Acrylonitrile, Vinyl 
chloride, Ethylene oxide
N -Acetyl-S-(2-hydroxyethyl)-L-cysteine HEMA 2.52±0.61 not reported
Benzene N -Acetyl-S-(phenyl)-L-cysteine PMA 1.08±0.27 0.82±0.26
trans,trans -Muconic acid MU 173±21 74±12
1-Bromopropane N -Acetyl-S-(n -propyl)-L-cysteine BPMA 16.4±0.4 5±1.3
1,3-Butadiene N -Acetyl-S-(3,4-dihydroxybutyl)-L-cysteine DHBMA 277±24 162±10
N -Acetyl-S-(2-hydroxy-3-butenyl)-L-cysteine MHBMA2 2.01±0.11 not reported
N -Acetyl-S-(4-hydroxy-2-buten-1-yl)-L-cysteine MHBMA3 54.8±8.3 6.81±0.99
Carbon-disulfide 2-Thioxothiazolidine-4-carboxylic acid TTCA 20.6±2.3 27.6±1
Crotonaldehyde N -Acetyl-S-(3-hydroxypropyl-1-methyl)-L-cysteine HPMMA 1670±10 273±7
Cyanide 2-Aminothiazoline-4-carboxylic acid ATCA 117±17 57.5±7.9
N,N-Dimethylformamide N -Acetyl-S-(N -methylcarbomoyl)-L-cysteine AMCC 340±26 129±18
Propylene oxide N -Acetyl-S-(2-hydroxypropyl)-L-cysteine 2HPMA 305±12 42.6±6.9
Styrene Mandelic acid MA 242±9 81±13
N -Acetyl-S-(1-phenyl-2-hydroxyethyl)-L-cysteine and 
N -Acetyl-S-(2-phenyl-2-hydroxyethyl)-L-cysteine
PHEMA 0.97±0.32 not reported
Styrene, Ethylbenzene Phenylglyoxylic acid PGA 290±18 138±4
Toluene N -Acetyl-S-(benzyl)-L-cysteine BMA 5.17±0.83 3.54±0.15
Xylene 2-Methylhippuric acid 2-MHA 73.5±4.8 20.8±6.3
3-Methyl & 4-Methylhippuric acids 3-MHA+4-MHA 531±7 109±14
(a)CDC analysis; data were converted from ng/mL to μg/kg using the density of the urine (1.019 g/mL)
(b)
The reference mass fraction value is the mean of results obtained using one analytical technique. The expanded uncertainty, U, is calculated as U 
= kuc, where uc is one standard deviation of the analyte mean, and the coverage factor, k, is determined from the Student’s t-distribution 
corresponding to the associated degrees of freedom and a 95 % confidence level for each analyte. The effective coverage factor k is 4.30
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Table 5
Reference mass fraction values (mg/kg) for additional analytes in SRM 3672 organic contaminants in 
smokers’ urine and SRM 3673 organic contaminants in non-smokers’ urine
SRM 3672(a,b) (k) SRM 3673(a,b) (k)
Creatinine 734±5 (2.07) 505±2 (2.07)
Nicotine(c) 0.731±0.018 (2.16) 0.029±0.002 (2.36)
Ibuprofen(c) 0.122±0.005 (2.16) 0.35±0.002 (2.36)
Caffeine(c) 2.65±0.05 (2.16) 3.58±0.05 (2.36)
Cotinine(c) 1.09±0.02 (2.16) 0.024±0.001 (2.36)
Theobromine(c) 3.31±0.09 (2.16) 5.94±0.15 (2.36)
3-Hydroxycotinine(c) 3.46±0.09 (2.16) not reported
(a)NIST analysis
(b)
The reference mass fraction value is the mean of results obtained using one analytical technique. The expanded uncertainty, U, is calculated as U 
= kuc, where uc is one standard deviation of the analyte mean, and the coverage factor, k, is determined from the Student’s t-distribution 
corresponding to the associated degrees of freedom and a 95 % confidence level for each analyte. The effective coverage factor k is given in the 
table
(c)
Mass fraction of non-conjugated species only
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